Matthew J Ellington Selected Research

Lactams

1/2022

Bacterial genotypic and patient risk factors for adverse outcomes in Escherichia coli bloodstream infections: a prospective molecular epidemiological study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew J Ellington Research Topics

Disease

6	Infections 12/2020 - 10/2013
1	Cross Infection (Nosocomial Infection) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Staphylococcal Infections 05/2015
1	Wounds and Injuries (Trauma) 10/2013
1	Bacteremia 06/2012
1	Keratitis 04/2012
1	Urinary Tract Infections (Urinary Tract Infection) 10/2006

Drug/Important Bio-Agent (IBA)

4	carbapenemaseIBA 01/2022 - 10/2013
2	Carbapenems (Carbapenem Antibiotics)IBA 12/2020 - 01/2018
1	LactamsIBA 01/2022
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2022
1	Methicillin (Metin)FDA Link 01/2018
1	Fusidic Acid (Fucithalmic)IBA 05/2015
1	Serine (L-Serine)FDA Link 10/2013
1	DNA (Deoxyribonucleic Acid)IBA 06/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2012
1	Fosfomycin FDA Link 10/2006
1	beta-Lactamases (beta-Lactamase)IBA 10/2006

Therapy/Procedure

1	Hand Hygiene 01/2020
1	Therapeutics 01/2017
1	Contact Lenses 04/2012